ARTICLES

Insights from the 2017 Global Transparency & Reporting Congress

05.23.17 | BY Amy Greenstein and Caroline Franco
The 2017 “Global Transparency & Reporting Congress” in London highlighted the opportunities and challenges for Life Sciences companies as they navigate the dynamic global transparency reporting environment. Regarding challenges, keeping Read more

What is a CMS Education Letter anyway?

03.10.17 | BY Emily Gerdts
As this year’s Sunshine Act filing deadline rapidly approaches, companies are busy preparing and validating aggregate spend data. With data so readily available, CMS has also taken a more compliance-driven Read more

Portugal: New decree issued regarding transparency

02.07.17 | BY Veronique Monjardet
The Portuguese Ministry of Health issued a new law, (Decree-Law 5/2017), on January 6th 2017, which creates additional reporting obligations for Life Sciences companies and further promotes transparency in promotional Read more

Anti-corruption: All roads lead to enforcement

02.06.17 | BY Amy Greenstein, Caroline Franco, Darren Jones and Veronique Monjardet
Abstract:  When it comes to corruption, Life Sciences companies are a frequent target of investigation and enforcement.  The French enactment of Sapin II is the latest in a long line Read more